In: The breast, 2020, vol. 52, p. 110-115
Background: Corona Virus Disease 19 (COVID-19) had a worldwide negative impact on healthcare systems, which were not used to coping with such pandemic. Adaptation strategies prioritizing COVID-19 patients included triage of patients and reduction or re-allocation of other services. The aim of our survey was to provide a real time international snapshot of modifications of breast cancer...
|
In: Plos one, 2011, vol. 6, no. 3, p. e18207
Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, genetically diverse HIV-1 clades have evolved, and a key question left unanswered is whether neutralizing antibodies can confer cross-clade protection in vivo. The novel human monoclonal antibody HGN194 was isolated from an individual infected with an HIV-1 clade AG recombinant circulating recombinant...
|
In: Supportive Care in Cancer, 2014, vol. 22, no. 9, p. 2425-2434
|
In: Breast Cancer Research and Treatment, 2014, vol. 143, no. 1, p. 159-169
|
In: Mammalian Genome, 2004, vol. 15, no. 11, p. 935-941
|
In: Breast Cancer Research and Treatment, 2011, vol. 126, no. 1, p. 221-226
|
In: Oecologia, 2010, vol. 164, no. 4, p. 959-969
|
In: Archives of Gynecology and Obstetrics, 2007, vol. 276, no. 4, p. 327-331
|
In: Breast Cancer Research and Treatment, 2011, vol. 129, no. 3, p. 799-807
|
In: Breast Cancer Research and Treatment, 2012, vol. 131, no. 2, p. 491-499
|